To determine the half- life of Anti snake venom (ASV) in the snake bite patients Snakebite causes blood-coagulation deficit leading to kidney failure; hence treatment is developed using anti-snake venom from frozen plasma. This cheap and effective treatment has saved the lives of many patients. The Hospital is a member of WHO Target Product Profile group and seeks guidance from Dr David Warrell, Emeritus Prof. of Tropical Medicine, from the University of Oxford, U.K. Institutional Ethics Committee approval for To determine the half- life of Anti snake venom (ASV) in the snake bite patients Research findings and scientific publications from our landmark studyASV Half-Life Study
Introduction
IEC Approval
IEC Approval
Publications